Serum levels of soluble intercellular adhesion molecule-1 and soluble vascular cell adhesion molecule-1 in asymptomatic carriers of hepatitis C virus

Journal of International Medical Research

Volumn 26, Issue 6, 1998, Pages 313-318

  Fukuda, Y ^a   Nakako, I ^a   Katano, Y ^a   Marui, A ^a   Hayakawa, T ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Asymptomatic carrier; Chronic hepatitis C; ELISA; Hepatitis C virus; Intercellular adhesion molecule 1; Soluble ICAM 1; Soluble VCAM 1; Vascular cell adhesion molecule 1

Indexed keywords

AMINOTRANSFERASE; INTERCELLULAR ADHESION MOLECULE 1; INTERFERON; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; SOLUBILITY; STATISTICAL ANALYSIS; VIRUS CARRIER;

EID: 0032405481     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/030006059802600605     Document Type: Article

References (29)

1. Makgoba MW, Sanders ME, Ginther-Luce GE, et al: Functional evidence that intercellular adhesion molecule-1 (ICAM-1) is a ligand for LFA-1 in cytotoxic T cell recognition. Eur J Immunol 1988; 18: 636 -640.
2. Hemler ME, Elices MJ, Parker C, et al: Structure of the integrin VLA-4 and its cell-cell and cell-matrix adhesion functions. Immunol Rev 1990; 114: 45-65.
3. Postigó AA, Teixidó J, Sánchez-Madrid F: The α4β1/VCAM-1 adhesion pathway in physiology and disease. Res Immunol 1994; 144: 723-735.
4. Volpes R, van Den Oord JJ, Desmet VJ: Immunohistochemical study of adhesion molecules in liver inflammation. Hepatology 1990; 12: 59-65.
5. Horiike N, Onji M, Kumon I, et al: Intercellular adhesion molecule-1 expression on the hepatocyte membrane of patients with chronic hepatitis B and C. Liver 1993; 13: 10-14.
6. Volpes R, van Den Oord JJ, Desmet VJ: Vascular adhesion molecules in acute and chronic liver inflammation. Hepatology 1992; 15: 269-275.
7. García-Monzón C, Sánchez-Madrid F, García-Buey L, et al: Vascular adhesion molecule expression in viral chronic hepatitis: evidence of neoangiogenesis in portal tract. Gastroenterology 1995; 108: 231-241.
8. Adams DH, Mainolfi E, Burra P, et al: Detection of circulating intercellular adhesion molecule-1 in chronic liver diseases. Hepatology 1992: 16: 810-814.
9. Hyodo I, Jinno K, Tanimizu M, et al: Detection of circulating intercellular adhesion molecule-1 in hepatocellular carcinoma. Int J Cancer 1993; 55: 775-779.
10. Horiike N, Onji M, Kumamoto I, et al: Soluble intercellular adhesion molecule-1 in serum in chronic hepatitis B and C. J Gastroenterol 1994; 29: 455-459.
11. Lim AG, Jazrawi RP, Ahmed HA, et al: Soluble intercellular adhesion molecule-1 in primary biliary cirrhosis: relationship with disease stage, immune activity and cholestasis. Hepatology 1994; 20: 882 -888.
12. Adams DH, Burra P, Hubscher SG, et al: Endothelial activation and circulating vascular adhesion molecules in alcoholic liver disease. Hepatology 1994; 19: 588-594.
13. Lim AG, Jazrawi RP, Levy JH, et al: Soluble E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in primary biliary cirrhosis. J Hepatol 1995; 22: 416-422.
14. Simpson KJ, Jones AL, Howie AF, et al: Soluble adhesion molecules and interleukin-2 receptor concentrations in patients with autoimmune chronic hepatitis. Eur J Gastroenterol Hepatol 1995; 7: 455-460.
15. Marui A, Fukuda Y, Koyama Y, et al: Serum levels of soluble intercellular adhesion molecule-1 and soluble vascular cell adhesion molecule-1 in liver disease, and their changes by treatment with interferon. J Int Med Res 1995; 24: 258-265.
16. Soresi M, Cervello M, Lipani G, et al: Circulating intercellular adhesion molecule-1 in patients with hepatocellular carcinoma. Eur J Gastroenterol Hepatol 1997; 9: 805-809.
17. Tremolada F, Casarin C, Alberti A, et al: Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis. J Hepatol 1992; 16: 273-281.
18. Naito M, Hayashi N, Hagiwara H, et al: Serum hepatitis C virus RNA quantity and histological features of hepatitis C virus carriers with persistently normal ALT levels. Hepatology 1994; 19: 871-875.
19. Bruno S, Rossi S, Petroni ML, et al: Normal aminotransferase concentrations in patients with antibodies to hepatitis C. BMJ 1994; 308: 697.
20. Hearley CJ, Chapman RWG, Fleming KA. Liver histology in hepatitis C infection: a comparison between patients with persistently normal or abnormal transaminases. Gut 1995; 37: 274-278.
21. Prati D, Capelli C, Zanella A, et al: Influence of different hepatitis C virus genotypes on the course of asymptomatic hepatitis C virus infection. Gastroenterology 1996; 110: 178-183.
22. Stanley AJ, Haydon GH, Piris J, et al: Assessment of liver histology in patients with hepatitis C and normal transaminase levels: Eur J Gastroenterol Hepatol 1996; 8: 869-872.
23. Kuzushita N, Hayashi N, Katayama K, et al: Increased frequency of HLA DR13 in hepatitis C virus carriers with persistently normal ALT levels. J Med Virol 1996; 48: 1-7.
24. Corny-Cantilena C, VanRaden M, Gibble J, et al: Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 1996; 334: 1691-1696.
25. Alter HJ, Corny-Cantilena C, Melpolder J, et al: Hepatitis C in asymptomatic blood donors. Hepatology 1997; 26 (Suppl 1): 29S-33S.
26. Marcellin P, Levy S, Erlinger S: Therapy of hepatitis C: patients with normal aminotransferase levels. Hepatology 1997; 26 (Suppl 1): 133S-136S.
27. Desmet VJ, Gerber M, Hoonagle JH, et al: Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 1513-1520.
28. Yasuda K, Iino S: Natural courses and pathophysiology of asymptomatic HCV carriers. Nihon Rinsho 1995; 53 (Suppl 1): 36-42 (in Japanese).
29. Rothlin R, Mainofli EA, Czajkowski M, et al: A form of circulating ICAM-1 in human serum. J Immunol 1991; 147: 3788-3793.